Skip to main content

Therapeutic Uses of Radiopharmaceuticals in Nuclear Medicine

  • Chapter
Fundamentals of Nuclear Pharmacy
  • 290 Accesses

Abstract

Hyperthyroidism is a disease manifested by excessive thyroid hormone activity and can arise from a number of pathogenic processes. Several strategies are employed in the treatment of hyperthyroidism, e.g., use of antithyroid drugs such as propylthiouracil or methimazole, thyroidectomy, and use of 131I. Each of these methods has its own merits and disadvantages, but drug therapy and 131I treatment are the most common choices.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Suggested Reading

  • Becker D, Hurley JR. Radioiodine treatment of hyperthyroidism. In: Sandler MP, Coleman RE, Walkers FJT, et al., eds. Diagnostic Nuclear Medicine. 3rd ed. Baltimore: Williams and Wilkins; 1996:943.

    Google Scholar 

  • Farhanghi M, Holmes RA, Volkert WA, et al. Samarium-153-EDTMP: pharmacokinetics, toxicity and pain response using an escalating dose schedule in treatment of metastatic bone pain. J Nucl Med. 1992; 33:1451.

    PubMed  CAS  Google Scholar 

  • Hurley JR, Becker DV. Treatment of thyroid cancer with radioiodine (131I). In: Sandler MP, Coleman RE, Walkers FJT, et al., eds. Diagnostic Nuclear Medicine. 3rd ed. Baltimore: Williams and Wilkins; 1996:959.

    Google Scholar 

  • Maxon HR III, Smith HD. Radioiodine-131 in the diagnosis and treatment of metastatic well-differentiated thyroid cancer. Endocrinol Metab Clin North Am. 1990; 19:685.

    PubMed  Google Scholar 

  • Maxon HR, Thomas SR, Hertzberg VS, et al. Rhenium-186 hydroxyethyledene diphosphonate for the treatment of painful osseous metastases. Semin Nucl Med. 1992; 22:33.

    Article  PubMed  Google Scholar 

  • Robinson RG, Preston DF, Schiefelbein M, et al. Strontium-89 therapy for the palliation of pain due to osseous metastases. JAMA. 1995; 274:420.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Saha, G.B. (1998). Therapeutic Uses of Radiopharmaceuticals in Nuclear Medicine. In: Fundamentals of Nuclear Pharmacy. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-2934-4_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-2934-4_14

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4757-2936-8

  • Online ISBN: 978-1-4757-2934-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics